Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,169.00
+68.00 (6.18%)
Oct 16, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 20.22 billion as of October 16, 2026. It is the 39,341st most valuable company in the world and the 2,449th biggest in South Korea. Its market cap has decreased by 25.02% in one year.
Market Cap
20.22B
Enterprise Value
21.37B
Revenue
4.36B
Global Rank
Country Rank
#2,449 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 20.22B, a decrease of -77.59%. That is a compound annual growth rate of -48.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 20.22B | -29.62% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 143.89B |
| Genexine | 121.20B |
| MedPacto | 109.17B |
| Vaxcell-Bio Therapeutics | 95.24B |
| iNtRON Biotechnology | 84.33B |
| Prestige BioPharma | 68.15B |
| Amicogen | 64.89B |
| ENCell | 55.81B |